Join a study exploring potential treatments
with a new class of investigational medication
Major Depressive Disorder (MDD)
Bipolar I Disorder (BD-I)
Bipolar I or Bipolar II Disorder(BD-I or BD-II)
Bipolar I Disorder (aged 18-75)
Alzheimer's Disease (AD)
Alzheimer's Disease (AD)
Alzheimer's Disease (AD)
Generalized Anxiety Disorder (GAD)
Autism (ASD aged 13-17)
Postpartum Depression (PPD)
Migraine Disorder (aged 6-17)
Migraine Disorder (aged 6-17)
Attention-Deficit/Hyperactivity Disorder (ADHD aged 13-17)
ADHD (aged 4-5)
Schizophrenia (SCZ)